Cartiva competitorsClear all

Fusion Antibodies's top competitors include Tissue Regenix Group, Orthofix and Affymetrix.
Fusion Antibodies
Fusion Antibodies
Fusion Antibodies is a CRO that offers a range of world class services in antibody production, development, characterization and optimization.
Tissue Regenix Group
Tissue Regenix Group
Tissue Regenix uses its patented dCELL technology to address many clinical needs such as sports medicine, wound care and heart valve replacement.
Orthofix
Orthofix
Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide.
Affymetrix
Affymetrix
Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell protein, and gene level.
Founding Date
Founding Date
2001
Founding Date
2006
Founding Date
1980
Founding Date
1994
Type
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Belfast, GB HQ
Locations
Swillington, GB HQ
San Antonio, US
Locations
Z.a.i., IT HQ
São Paulo, BR
Willemstad, CW
Arcueil, FR
Ottobrunn, DE
Sona, IT
San Juan, PR
see more
Locations
Santa Clara, US HQ
Vienna, AT
Shanghai, CN
Singapore, SG
High Wycombe, GB
San Diego, US
see more
Employees
Employees
323% increase
Employees
61
Employees
95411% increase
Employees
N/A
Valuation ($)
Valuation ($)
N/A
Valuation ($)
129.7 m
Valuation ($)
1 b
Valuation ($)
N/A
Twitter followers
Twitter followers
967
Twitter followers
731
Twitter followers
N/A
Twitter followers
3
Alexa Website Rank
Alexa Website Rank
1032809
Alexa Website Rank
638427
Alexa Website Rank
298367
Alexa Website Rank
454220

Financial

Revenue (est.)
Revenue (est.)
£2.2m (FY, 2019)
Revenue (est.)
£11.6m (FY, 2018)
Revenue (est.)
$453m (FY, 2018)
Revenue (est.)
$359.8m (FY, 2015)
Cost of goods
Cost of goods
£1.4m (FY, 2019)
Cost of goods
£5.7m (FY, 2018)
Cost of goods
$96.6m (FY, 2018)
Cost of goods
$110.8m (FY, 2015)
Gross profit
Gross profit
£804k (FY, 2019)
Gross profit
£5.9m (FY, 2018)
Gross profit
$356.4m (FY, 2018)
Gross profit
$249m (FY, 2015)
Net income
Net income
(£1.3m) (FY, 2019)
Net income
(£8.3m) (FY, 2018)
Net income
$13.8m (FY, 2018)
Net income
$10.1m (FY, 2015)
For sources of this data, please see the company profile

View company profiles

Tissue Regenix Group
HQ
Swillington, GB
Employees
61

Tissue Regenix uses its patented dCELL technology to address many clinical needs such as sports medicine, wound care and heart valve replacement.

View company
Orthofix
HQ
Z.a.i., IT
Employees
954↑ 11% increase

Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide.

View company
Affymetrix
HQ
Santa Clara, US

Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell protein, and gene level.

View company